Isotopia Announces Official Commercial Launch of Isoprotrace® in Germany in Partnership with DSD Pharma

Prostate cancer remains one of the most common cancers among men in Germany, with over 70,000 new cases diagnosed each year. Accurate imaging plays a crucial role in precise diagnosis and effective treatment planning. Prostate cancer remains one of the most common cancers among men inGermany, with over 70,000 new cases diagnosed each year. Accurate imaging plays a crucial role in precise diagnosis and effective treatment planning. "We are thrilled to be working with DSD Pharma to bring...

Prostate cancer remains one of the most common cancers among men in Germany, with over 70,000 new cases diagnosed each year. Accurate imaging plays a crucial role in precise diagnosis and effective treatment planning.

"We are thrilled to be working with DSD Pharma to bring Isoprotrace® to the German market," said Tzachi Levy, GM of Isotopia's aseptic plant "Germany is a key market for Isoprotrace®, and we are confident that this collaboration will ensure the successful introduction and accessibility of this innovative product to healthcare providers across the country."

Dr. Susanne Dorudi, Managing Director at DSD Pharma, added, "We are proud to partner with Isotopia to introduce Isoprotrace® to Germany. This collaboration allows us to offer German healthcare professionals a groundbreaking imaging solution. We are excited about the potential impact of this product and look forward to its success in the German market."

Isoprotrace® has already been approved in the Netherlands and is expected to be available soon in over 10 EU countries. With a robust and reliable supply chain and a proven compliance record, Isotopia is committed to expanding patient access to this innovative product, while enhancing diagnostic accuracy and improving treatment outcomes for prostate cancer.

About Isotopia

Isotopia is a leading innovator in the development of radiopharmaceuticals for molecular imaging and therapy. With a focus on providing top-quality, advanced solutions, Isotopia is committed to improving patient care through precision medicine.

About DSD Pharma

DSD Pharma is a well-established pharmaceutical distribution company operating in Austria, Germany, and Switzerland, specializing in the distribution of cutting-edge healthcare solutions. With a strong network and profound expertise in the pharmaceutical industry, DSD Pharma partners with leading global companies to bring innovative products to the market.

Contact: [email protected]

Logo - https://mma.prnewswire.com/media/2337282/4537248/Isotopia_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/isotopia-announces-official-commercial-launch-of-isoprotrace-in-germany-in-partnership-with-dsd-pharma-302396768.html